<div class="pk-crumbs" data-crumbs="[{&quot;label&quot;:&quot;Drugs&quot;,&quot;href&quot;:&quot;README.md&quot;},{&quot;label&quot;:&quot;C03D&quot;,&quot;href&quot;:&quot;atc/C03D.md&quot;},{&quot;label&quot;:&quot;canrenone&quot;}]"></div>
<div class="pk-recnav" data-items="[{&quot;id&quot;:&quot;Canrenone_Suyagh2012_final_pharmacokinetic_model&quot;,&quot;label&quot;:&quot;Suyagh_2012_final_pharmacokinetic_model&quot;,&quot;group&quot;:&quot;popPK&quot;,&quot;href&quot;:&quot;drugs/drug_canrenone/Canrenone_Suyagh2012_final_pharmacokinetic_model.md&quot;,&quot;status&quot;:&quot;needs review&quot;,&quot;css&quot;:&quot;pk-badge--orange&quot;,&quot;here&quot;:false},{&quot;id&quot;:&quot;Canrenone_Suyagh2012_median&quot;,&quot;label&quot;:&quot;Suyagh_2012_median&quot;,&quot;group&quot;:&quot;popPK&quot;,&quot;href&quot;:&quot;drugs/drug_canrenone/Canrenone_Suyagh2012_median.md&quot;,&quot;status&quot;:&quot;needs review&quot;,&quot;css&quot;:&quot;pk-badge--orange&quot;,&quot;here&quot;:false},{&quot;id&quot;:&quot;Canrenone_Suyagh2013_reference&quot;,&quot;label&quot;:&quot;Suyagh_2013_reference&quot;,&quot;group&quot;:&quot;popPK&quot;,&quot;href&quot;:&quot;drugs/drug_canrenone/Canrenone_Suyagh2013_reference.md&quot;,&quot;status&quot;:&quot;needs review&quot;,&quot;css&quot;:&quot;pk-badge--orange&quot;,&quot;here&quot;:false}]"></div>

# canrenone

- **generic name:** canrenone
- **ATC codes:** `C03DA03`
- **DrugBank:** [DB12221](https://go.drugbank.com/drugs/DB12221) · **PubChem:** [CID 13789](https://pubchem.ncbi.nlm.nih.gov/compound/13789)
- **molar mass:** 340.4559 g/mol (C22H28O3) — DrugBank
- **groups:** investigational

## About

Canrenone is an antimineralocorticoid (aldosterone antagonist) that has been investigated for use as a potassium-sparing diuretic in cardiovascular conditions. It is considered investigational and is not an approved medicine in the European Union.

<small>Summary written by `glm-5.3-flash` from [Wikidata Q5033475](https://www.wikidata.org/wiki/Q5033475) and the WHO ATC classification; not checked by a person.</small>

## Molecules and molar masses

> The molar mass each model uses to convert mass to molar concentration and to form a metabolite molecule for molecule. Looked up, never estimated: DrugBank for the drug, the paper's own value or the PubChem entry matched to the paper's name for a metabolite.

| molecule | role | molar mass (g/mol) | formula | source | PubChem | records |
|---|---|---|---|---|---|---|
| canrenone | parent | 340.456 | C22H28O3 | DrugBank | [13789](https://pubchem.ncbi.nlm.nih.gov/compound/13789) | Ho_1984, Lass_2024, Suyagh_2012, Suyagh_2013 |
| 7-alpha-thiomethylspironolactone | metabolite | 388.6 | — | the paper | — | Lass_2024 |
| potassium canrenoate | metabolite | 396.568 | C22H29KO4 | PubChem | [23671691](https://pubchem.ncbi.nlm.nih.gov/compound/23671691) | Suyagh_2012, Suyagh_2013 |
| spironolactone | metabolite | 416.576 | C24H32O4S | PubChem | [5833](https://pubchem.ncbi.nlm.nih.gov/compound/5833) | Ho_1984, Lass_2024 |
| total metabolites | metabolite | — (mass units only) | — | — | — | — |

## Extraction summary

| extracted at | time | popPK e/r/o | PD e/r/o (paper) | PGx e/r/o | tokens in/out | LLM | papers | GROBID/JATS | OA/non-OA | NONMEM |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-28 10:19 | 17:05 | 0/1/5 | 0/0/0 | 0/0/0 | 214,645/50,150 | ollama / qwen3.8:27b-mtp-q8_0 | 4 | 3/1 | 4/0 | 0 |

## popPK records

| status | detail | model | model structure | params | citation | doi |
|---|---|---|---|---|---|---|
| <span class="pk-badge pk-badge--orange">needs review</span> <span class="pk-badge pk-badge--red" title="re-read by gpt-oss:120b (not confirmed, agreement 0.571). The first reading is what the record holds.">cross-check: disputed</span><br><sub>blocking: disposition incomplete — only volume extracted — the engineer needs clearance/e…</sub><br><sub>route_to: `human_review`</sub> | [Lass_2024_estimate_1](drugs/drug_canrenone/Canrenone_Lass2024_estimate_1.md) | — | general linear (no model) | 1 | Lass J et al., Pharmacokinetics of oral spironolactone…, European journal of clinica… (2024) | [10.1007/s00228-023-03599-w](https://doi.org/10.1007/s00228-023-03599-w) |
| <span class="pk-badge pk-badge--orange">needs review</span> <span class="pk-badge pk-badge--red" title="re-read by gpt-oss:120b (not confirmed, agreement 0.571). The first reading is what the record holds.">cross-check: disputed</span><br><sub>blocking: disposition incomplete — only volume extracted — the engineer needs clearance/e…</sub><br><sub>route_to: `human_review`</sub> | [Lass_2024_estimate_2](drugs/drug_canrenone/Canrenone_Lass2024_estimate_2.md) | — | general linear (no model) | 1 | Lass J et al., Pharmacokinetics of oral spironolactone…, European journal of clinica… (2024) | [10.1007/s00228-023-03599-w](https://doi.org/10.1007/s00228-023-03599-w) |
| <span class="pk-badge pk-badge--orange">needs review</span> <span class="pk-badge pk-badge--green" title="re-read by gpt-oss:120b (confirmed, agreement 1.0). The first reading is what the record holds.">cross-checked ✓</span><br><sub>caveat: a molar mass is missing: the model forms 1 mg of metabolite per mg of parent converted, not one molecule per…</sub><br><sub>blocking: T3_topology_template</sub><br><sub>blocking: T3_metabolite_built[canrenone]</sub><br><sub>route_to: `scholar`</sub> | [Suyagh_2012_final_pharmacokinetic_model](drugs/drug_canrenone/Canrenone_Suyagh2012_final_pharmacokinetic_model.md) | ▶ model + simulator | 1-compartment, oral | 3 | Suyagh M et al., Population pharmacokinetic model of can…, British journal of clinical… (2012) | [10.1111/j.1365-2125.2012.04257.x](https://doi.org/10.1111/j.1365-2125.2012.04257.x) |
| <span class="pk-badge pk-badge--orange">needs review</span> <span class="pk-badge pk-badge--green" title="re-read by gpt-oss:120b (confirmed, agreement 1.0). The first reading is what the record holds.">cross-checked ✓</span><br><sub>caveat: a molar mass is missing: the model forms 1 mg of metabolite per mg of parent converted, not one molecule per…</sub><br><sub>blocking: T3_topology_template</sub><br><sub>blocking: T3_metabolite_built[canrenone]</sub><br><sub>route_to: `scholar`</sub> | [Suyagh_2012_median](drugs/drug_canrenone/Canrenone_Suyagh2012_median.md) | ▶ model + simulator | 1-compartment, oral | 4 | Suyagh M et al., Population pharmacokinetic model of can…, British journal of clinical… (2012) | [10.1111/j.1365-2125.2012.04257.x](https://doi.org/10.1111/j.1365-2125.2012.04257.x) |
| <span class="pk-badge pk-badge--orange">needs review</span> <span class="pk-badge pk-badge--red" title="re-read by gpt-oss:120b (not confirmed, agreement 0.222). The first reading is what the record holds.">cross-check: disputed</span><br><sub>blocking: unreported model parameter default(s): ka</sub><br><sub>route_to: `scholar`</sub> | [Suyagh_2013_reference](drugs/drug_canrenone/Canrenone_Suyagh2013_reference.md) | ▶ model + simulator | 1-compartment, oral | 3 | Suyagh M et al., Potassium canrenoate treatment in paedi…, Journal of hypertension (2013) | [10.1097/HJH.0b013e3283626994](https://doi.org/10.1097/HJH.0b013e3283626994) |
| <span class="pk-badge pk-badge--red">rejected</span> <span class="pk-badge pk-badge--red" title="re-read by gpt-oss:120b (not confirmed, agreement 0.375). The first reading is what the record holds.">cross-check: disputed</span><br><sub>blocking: no distribution volume and no clearance/elimination — not a compartmental popPK…</sub><br><sub>route_to: `human_review`</sub> | [Ho_1984_reference](drugs/drug_canrenone/Canrenone_Ho1984_reference.md) | — | parent + metabolite (no model) | 2 | Ho PC et al., Pharmacokinetics of canrenone and metab…, European journal of clinica… (1984) | [10.1007/BF00549592](https://doi.org/10.1007/BF00549592) |

<details class="legend">
<summary>Badge legend — what each badge means</summary>
<table><thead><tr><th>badge</th><th>what it means</th></tr></thead><tbody><tr><td><span class="pk-badge pk-badge--green">curated</span></td><td>hand-authored by a person — an exemplar, not an extraction.</td></tr><tr><td><span class="pk-badge pk-badge--green">extracted</span></td><td>the pipeline accepted the record: every closed-form check it could run passed.</td></tr><tr><td><span class="pk-badge pk-badge--green">reviewed — candidate</span></td><td>the reviewer ran the built model against the paper's own reported values and they agree — the best automatic verdict there is.</td></tr><tr><td><span class="pk-badge pk-badge--green">accepted (caveats)</span></td><td>the model replicates the paper, but an advisory check failed — the record page names the caveat under the badge and the drug page shows it under the status.</td></tr><tr><td><span class="pk-badge pk-badge--orange">needs review</span></td><td>extracted, then a check failed or a value looks implausible. The numbers are shown as read, not endorsed.</td></tr><tr><td><span class="pk-badge pk-badge--orange">built, not shipped</span></td><td>a model was built, but a core parameter fell back to a library default, so it is not shipped.</td></tr><tr><td><span class="pk-badge pk-badge--red">rejected</span></td><td>not accepted — the record is not a compartmental model, or nothing usable was extracted.</td></tr><tr><td><span class="pk-badge pk-badge--neutral">not modelled</span></td><td>pipeline state, not a judgement: no model has been built for this record yet (likewise `not simulated`).</td></tr><tr><td><span class="pk-badge pk-badge--stale">stale</span></td><td>the reviewer's verdict predates the latest re-run of the paper — treat the status as out of date, not as current.</td></tr><tr><td><span class="pk-badge pk-badge--green">cross-checked ✓</span></td><td>every independent reader agreed on every compared field. With more than one reader the badge counts them, e.g. 'cross-checked ✓ 2/2'.</td></tr><tr><td><span class="pk-badge pk-badge--orange">cross-check: partial</span></td><td>a reader differs on a non-structural field (a population label, a flag), or the readers do not all agree with each other.</td></tr><tr><td><span class="pk-badge pk-badge--red">cross-check: disputed</span></td><td>at least one reader differs on a structural parameter — a clearance, a volume, ka, a lag. The record still holds the FIRST reading; the disagreement is a signal for a reviewer, never an automatic correction.</td></tr><tr><td><span class="pk-badge pk-badge--species">rat</span></td><td>the data come from an animal (or in-vitro) study, not from people. The record, its model and its simulation are kept — they describe that species.</td></tr></tbody></table>
<p><small>The first badge is the record's <b>status</b> — what the pipeline and the reviewer concluded. A second badge, when present, is the <b>cross-check</b>: whether a model of another family, re-reading the same paper, extracted the same numbers. They are independent — a rejected record can be cross-checked, and a confirmed reading can still fail a plausibility check.</small></p>
</details>

## Coverage

- **PubMed hits:** 13 matched, 13 returned
- **screened:** 5  ·  **relevant:** 5
- **records:** 6  ·  extracted 0  ·  needs_review 5  ·  rejected 1  ·  stale 0
- **scholar-agent fallback query used:** not captured

## Full text wanted

_4 paper(s) judged relevant from the abstract, with no full text on disk — paywalled, or the resolver could not reach them. Follow the DOI, then save the PDF into `papers/` as `&lt;save as&gt;.pdf` and re-run the extraction._

| save as | citation | domain | score | DOI | PubMed | why wanted |
|---|---|---|---|---|---|---|
| `Suyagh_2013.pdf` | Suyagh M et al., Potassium canrenoate treatment in paedi…, Journal of hypertension (2013) | popPK | 10 | [10.1097/HJH.0b013e3283626994](https://doi.org/10.1097/HJH.0b013e3283626994) | [23846862](https://pubmed.ncbi.nlm.nih.gov/23846862) | The paper is a population pharmacokinetic study of canrenone that explicitly reports numeric values for clearance, volume of distribution, and half-life in the text. |
| `Ho_1984.pdf` | Ho PC et al., Pharmacokinetics of canrenone and metab…, European journal of clinica… (1984) | popPK | 9 | [10.1007/BF00549592](https://doi.org/10.1007/BF00549592) | [6519151](https://pubmed.ncbi.nlm.nih.gov/6519151) | The study reports quantitative pharmacokinetic parameters (half-lives, accumulation ratio) for canrenone derived from a two-compartment model, with values explicitly stated in the text. |
| `Tatipalli_2021.pdf` | Tatipalli M et al., Model-Informed Optimization of a Pediat…, Pharmaceutics (2021) | popPK | 9 | [10.3390/pharmaceutics13060849](https://doi.org/10.3390/pharmaceutics13060849) | [34201093](https://pubmed.ncbi.nlm.nih.gov/34201093) | The paper describes a population PK model for canrenone, but the specific numeric parameter values are not present in the provided evidence text. |
| `Vergin_1986.pdf` | Vergin H et al., [Pharmacokinetic studies and bioavailab…, Arzneimittel-Forschung (1986) | popPK | 8 | not captured | [3707669](https://pubmed.ncbi.nlm.nih.gov/3707669) | The study reports PK parameters for canrenone using a 2-compartment model, but the specific numeric values for canrenone are not present in the provided text (only Bft values are explicitly listed). |

<sub>queue written 2026-09-28T10:03:03.313968+00:00</sub>

## Screened and excluded

| domain | paper | verdict | relevance | extractability | reason |
|---|---|---|---|---|---|
| popPK | Chaiben_2026 | irrelevant | 2 | 0 | The paper is a simulation study using a pre-existing model for spironolactone and canrenone to test adherence detection, and it does not report original quantitative PK parameter values for canrenone. |
| popPK | Pilkova_2024 | relevant | 4 | 5 | The study uses canrenone PK parameters (Vd, t1/2) for adherence modeling, but the values are cited from literature/SmPC rather than being original population PK estimates derived from the study's own data. |
| popPK | Tatipalli_2021 | relevant | 9 | 0 | The paper describes a population PK model for canrenone, but the specific numeric parameter values are not present in the provided evidence text. |
| popPK | Vergin_1986 | relevant | 8 | 2 | The study reports PK parameters for canrenone using a 2-compartment model, but the specific numeric values for canrenone are not present in the provided text (only Bft values are explicitly listed). |

---
<sub>Generated by `docs.py` (scholarv2) · newest extraction 2026-09-28 10:03 UTC</sub>
